Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568166810> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2568166810 abstract "Introduction: Isoniazid (INH) is an anti-tuberculosis drug used widely. It's efficacy in killing Mycobacterium tuberculosis has made this drug as both chemoprophylaxis and first-line therapy in combating tuberculosis (TB). However, irrational dosage of INH may potentiates to isoniazid-induced hepatitis. NA T2 gene is responsible to metabolize INH and change it to the inactive form. In the geneitself, single nucleotide polymorphisms (SNPs) mayappeared, creating changes on itsgenotype, phenotype, andfunctionalactivity on itskinematics. Genotypevariationshave created three phenotypes, namely rapid, intermediate, and slow acetylators. As TB shares comorbiditywith diabetes mellitus (DM), observing this genemight be useful to control progression and potential side effect from TB-DM treatment. This study aimed to analyze the NAT2acetylator status in TB and TB-DM patientsinKupang, Indonesia. Methods: 5 TBand 5 TB-DM patients in Kupang were surveyed. Vein puncture was performed prior to DNA isolation and sequencingto observethe NAT2 sequence. Results: The genotypes of TB patients are NAT2*4/*4 (rapid acetylator), NAT2*4/*6A (intermediate acetylator), and NAT2*13A/*6J (intermediate acetylator). TB-DM patients have NAT2*4/*4, NAT2*4/*5G (intermediate acetylator), NAT2*13A/*6J (intermediate acetylator), NAT2*6A/*6A (slow acetylator) and NAT2*7B/*7B (slow acetylator). Conclusion: NAT2 rapid acetylators may have risk on therapyfailure; slow acetylators may gain risk of INH-induced hepatitis. TBDM patients should be monitored fordouble burden potencies regarding their DM therapy and isoniazid-induced hepatitis. Thus, gene-guided regimen therapy might benefit the patients for more personalized and saferlNH therapy." @default.
- W2568166810 created "2017-01-13" @default.
- W2568166810 creator A5002994904 @default.
- W2568166810 creator A5006420823 @default.
- W2568166810 creator A5013341998 @default.
- W2568166810 creator A5016616576 @default.
- W2568166810 date "2015-01-01" @default.
- W2568166810 modified "2023-09-23" @default.
- W2568166810 title "Potencies Of NAT2 Gene As Safety Indicator For Controlling Hepatotoxicity In Tuberculosis-Diabetes Mellitus Treatment: A Preliminary Study" @default.
- W2568166810 hasPublicationYear "2015" @default.
- W2568166810 type Work @default.
- W2568166810 sameAs 2568166810 @default.
- W2568166810 citedByCount "0" @default.
- W2568166810 crossrefType "journal-article" @default.
- W2568166810 hasAuthorship W2568166810A5002994904 @default.
- W2568166810 hasAuthorship W2568166810A5006420823 @default.
- W2568166810 hasAuthorship W2568166810A5013341998 @default.
- W2568166810 hasAuthorship W2568166810A5016616576 @default.
- W2568166810 hasConcept C104317684 @default.
- W2568166810 hasConcept C126322002 @default.
- W2568166810 hasConcept C134018914 @default.
- W2568166810 hasConcept C135763542 @default.
- W2568166810 hasConcept C142724271 @default.
- W2568166810 hasConcept C2776029263 @default.
- W2568166810 hasConcept C2776688490 @default.
- W2568166810 hasConcept C2776967927 @default.
- W2568166810 hasConcept C2777975735 @default.
- W2568166810 hasConcept C2780035454 @default.
- W2568166810 hasConcept C2780459521 @default.
- W2568166810 hasConcept C2781069245 @default.
- W2568166810 hasConcept C2781413609 @default.
- W2568166810 hasConcept C54355233 @default.
- W2568166810 hasConcept C555293320 @default.
- W2568166810 hasConcept C71924100 @default.
- W2568166810 hasConcept C86803240 @default.
- W2568166810 hasConcept C98274493 @default.
- W2568166810 hasConceptScore W2568166810C104317684 @default.
- W2568166810 hasConceptScore W2568166810C126322002 @default.
- W2568166810 hasConceptScore W2568166810C134018914 @default.
- W2568166810 hasConceptScore W2568166810C135763542 @default.
- W2568166810 hasConceptScore W2568166810C142724271 @default.
- W2568166810 hasConceptScore W2568166810C2776029263 @default.
- W2568166810 hasConceptScore W2568166810C2776688490 @default.
- W2568166810 hasConceptScore W2568166810C2776967927 @default.
- W2568166810 hasConceptScore W2568166810C2777975735 @default.
- W2568166810 hasConceptScore W2568166810C2780035454 @default.
- W2568166810 hasConceptScore W2568166810C2780459521 @default.
- W2568166810 hasConceptScore W2568166810C2781069245 @default.
- W2568166810 hasConceptScore W2568166810C2781413609 @default.
- W2568166810 hasConceptScore W2568166810C54355233 @default.
- W2568166810 hasConceptScore W2568166810C555293320 @default.
- W2568166810 hasConceptScore W2568166810C71924100 @default.
- W2568166810 hasConceptScore W2568166810C86803240 @default.
- W2568166810 hasConceptScore W2568166810C98274493 @default.
- W2568166810 hasLocation W25681668101 @default.
- W2568166810 hasOpenAccess W2568166810 @default.
- W2568166810 hasPrimaryLocation W25681668101 @default.
- W2568166810 hasRelatedWork W1796807348 @default.
- W2568166810 hasRelatedWork W2031834826 @default.
- W2568166810 hasRelatedWork W2042063208 @default.
- W2568166810 hasRelatedWork W2118256120 @default.
- W2568166810 hasRelatedWork W2154724108 @default.
- W2568166810 hasRelatedWork W2159445805 @default.
- W2568166810 hasRelatedWork W2474725771 @default.
- W2568166810 hasRelatedWork W2507542905 @default.
- W2568166810 hasRelatedWork W2520865132 @default.
- W2568166810 hasRelatedWork W2785972922 @default.
- W2568166810 hasRelatedWork W2804231155 @default.
- W2568166810 hasRelatedWork W2936019466 @default.
- W2568166810 hasRelatedWork W2982207538 @default.
- W2568166810 hasRelatedWork W2983804704 @default.
- W2568166810 hasRelatedWork W3001004322 @default.
- W2568166810 hasRelatedWork W3118354754 @default.
- W2568166810 hasRelatedWork W3139422008 @default.
- W2568166810 hasRelatedWork W3195744920 @default.
- W2568166810 hasRelatedWork W80512758 @default.
- W2568166810 hasRelatedWork W2915323329 @default.
- W2568166810 isParatext "false" @default.
- W2568166810 isRetracted "false" @default.
- W2568166810 magId "2568166810" @default.
- W2568166810 workType "article" @default.